{"disease":{"id":"cancers-with-ntrk-ros1-or-alk-gene-fusions","name":"cancers with ntrk ros1 or alk gene fusions"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03066661","title":"Expanded Access to Entrectinib for Cancers With NTRK1/2/3, ROS1, or ALK Gene Fusions","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}